Contrary to your opinion, I see plenty of evidence that the funds will be used to complete the transition of Colostat to an IVDR-compliant product (requires $1.5 mil as outlined in the Prospectus). Previously the company successfully completed 7 clinical trials, alongside a range of other significant tangible activities, it's hardly a sham. The Directors receive standard remuneration, plus they own substantial shares, including full entitlements purchased in the capital raise, which I'm absolutely sure they'd like to see increase in value. As it stands, with a 38% uptake, the shares haven't been diluted quite so much, which partly offsets the challenges associated with having raised less funds.
- Forums
- ASX - By Stock
- Ann: Close of Rights Issue
Contrary to your opinion, I see plenty of evidence that the...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.9¢ | $10.30K | 103.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 95000 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 17500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 95000 | 0.100 |
1 | 27230 | 0.099 |
1 | 10000 | 0.098 |
1 | 30927 | 0.097 |
3 | 185500 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 17500 | 1 |
0.110 | 21670 | 2 |
0.115 | 132348 | 2 |
0.120 | 95076 | 2 |
0.130 | 4000 | 1 |
Last trade - 13.28pm 31/10/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
Harsh Shethia, Advisor
Harsh Shethia
Advisor
SPONSORED BY The Market Online